Publications
81
Citations
2,199
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1972
Utkarsh Acharya's work spans hematology and oncology, covering blood cancers (leukemia, lymphoma, myeloproliferative disorders), stem cell and CAR-T cell transplantation, and population-level studies of cancer outcomes and disparities. Recent work includes reviews and abstracts on treatments for blood disorders, cellular therapies, and large retrospective analyses examining survival differences by race, gender, and socioeconomic status across various cancers. The research combines clinical case-based reports with large database studies and quality-improvement projects relevant to cancer care delivery.
Publication output was fairly active from 2017-2022, dropped to zero in 2023-2024, then surged again in 2025 with a cluster of conference abstracts and papers.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody
Blood Reviews · 2025
- MPN-642: Glucagon-Like Peptide-1 Agonists and Clinical Outcomes in Polycythemia Vera: A Large-Scale Propensity-Matched Cohort Study
Clinical Lymphoma Myeloma & Leukemia · 2025
- Abstract 5856: Secondary hemophagocytic lymphohistiocytosis: A systematic review of incidence and prognostic outcomes
Cancer Research · 2025
- Abstract 4018: Primary gallbladder cancer association with cardiovascular mortality: A 20 year population-based retrospective study
Cancer Research · 2025
- Abstract 7107: Racial, gender and socioeconomic disparities in survival outcomes of gastrointestinal stromal tumors: a retrospective analysis from 2000 to 2021
Cancer Research · 2025
- Abstract 7381: Esophageal carcinoma association with chronic liver disease and cirrhosis mortality risk: A population based retrospective study
Cancer Research · 2025
- Impact of race, gender and socioeconomic status on Ewing sarcoma survival over two decades.
Journal of Clinical Oncology · 2025
- Chronic Neutrophilic Leukemia
2025
- Cancer-Associated Thrombosis in Hematologic Malignancies
2025
- POSTER: MPN-642 Glucagon-Like Peptide-1 Agonists and Clinical Outcomes in Polycythemia Vera: A Large-Scale Propensity-Matched Cohort Study
Clinical Lymphoma Myeloma & Leukemia · 2025
- ORAL ABSTRACT: MPN-642 Glucagon-Like Peptide-1 Agonists and Clinical Outcomes in Polycythemia Vera: A Large-Scale Propensity-Matched Cohort Study
Clinical Lymphoma Myeloma & Leukemia · 2025
- Targeting inflammation in sickle cell disease: Association of GLP-1 agonist use with improved survival and reduced sickle cell crisis and cardiopulmonary complications
Blood · 2025
- Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
Haematologica · 2022
- Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future
JCO Oncology Practice · 2022
- Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report
BMJ Open Quality · 2022
- Blood×12
- Clinical Lymphoma Myeloma & Leukemia×6
- StatPearls×5
- Cancer Research×5
- Journal of Clinical Oncology×4
- Daniel Li
Medicine · The Ohio State University
- Evandro D. Bezerra
Medicine · The Ohio State University
- Audrey M. Sigmund
Medicine · The Ohio State University
- Jay K. Mandula
Medicine · The Ohio State University
- Alexander W. Rankin
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile